Typically, disease progression during systemic therapy continues to be determined with imaging, including computed tomography; today, however, by using ICIs, atypical tumor replies such as for example pseudo-progression (2) frequently occur, rendering it tough to determine disease development only using imaging

Typically, disease progression during systemic therapy continues to be determined with imaging, including computed tomography; today, however, by using ICIs, atypical tumor replies such as […]

Continue reading